Reminder of the autoimmune component of AA.
Illustrate complex underlying hair follicle pathophysiology.
Educate global dermatologists on cellular pathways.
Redefined alopecia as pathologically driven autoimmune condition.
Streamlined training on JAK3 and TEC pathways.
Positioned Pfizer as pioneering scientific authority.

Debuting at the AAD congress, this flagship educational asset successfully smashed cosmetic myths by proving deep-rooted cellular destruction.

Trusted by some of the world's leading pharmaceutical, biotech and medical communications teams - including AstraZeneca, Pfizer, Sanofi, Takeda, Lundbeck and Samsung Biologics.



















